rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Gavin Corcoran

Director

Company insider

Files Form 4 as: Director, Verrica Pharmaceuticals; Chief R&D Officer, Sio Gene Therapies.

Every Form 4 they filed

In numbers

Trades disclosed
17
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
1
First trade
16 Jul 2018
Last trade
5 Jun 2026
Last filed
9 Jun 2026

Companies traded

Where they are an officer
Sio Gene TherapiesOfficer · last 15 Apr 20210 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
VRCA Verrica PharmaceuticalsDirector · Biotechnology · last 5 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
5 Jun 2026filed 9 Jun 2026VRCA Verrica Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
5 Jun 2026filed 9 Jun 2026VRCA Verrica Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
5 Jun 2025filed 9 Jun 2025VRCA Verrica Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
31 Mar 2025filed 2 Apr 2025VRCA Verrica Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—17,502 at $0.00filing
15 Apr 2021filed 19 Apr 2021Sio Gene Therapiesoption or derivativeSEC FORM 4 Code A—244,300 at $0.00filing
17 Mar 2021filed 19 Mar 2021Sio Gene TherapiesSEC FORM 4 Code A—16,001 at $0.00filing
17 Mar 2021filed 19 Mar 2021Sio Gene Therapiesoption or derivativeSEC FORM 4 Code D—16,001 at $0.00filing
12 Jun 2020filed 15 Jun 2020Axovant Gene Therapiesoption or derivativeSEC FORM 4 Code D—16,002 at $0.00filing
12 Jun 2020filed 15 Jun 2020Axovant Gene TherapiesSEC FORM 4 Code A—16,002 at $0.00filing
12 Jun 2020filed 15 Jun 2020Axovant Gene TherapiesSEC FORM 4 Code F$21K6,211 at $3.46filing
15 Apr 2020filed 17 Apr 2020Axovant Gene Therapiesoption or derivativeSEC FORM 4 Code A—63,700 at $0.00filing
15 Apr 2020filed 17 Apr 2020Axovant Gene Therapiesoption or derivativeSEC FORM 4 Code A—42,400 at $0.00filing
21 Sep 2019filed 24 Sep 2019Axovant Gene Therapiesoption or derivativeSEC FORM 4 Code A—32,003 at $0.00filing
15 Apr 2019filed 17 Apr 2019Axovant Sciencesoption or derivativeSEC FORM 4 Code A—767,000 at $0.00filing
15 Apr 2019filed 17 Apr 2019Axovant Sciencesoption or derivativeSEC FORM 4 Code A—200,000 at $0.00filing
16 Jul 2018filed 20 Jul 2018Axovant Sciencesoption or derivativeSEC FORM 4 Code A—250,000 at $0.00filing
16 Jul 2018filed 20 Jul 2018Axovant Sciencesoption or derivativeSEC FORM 4 Code A—200,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.